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Purpose. To compare preemptive multimodal analgesia (PMMA) without femoral nerve blocks (FNB) to PMMA including FNB
following totalknee arthroplasty(TKA).Methods.Ina prospective, controlled pilot study, subjectswith noninﬂammatory arthritis
undergoingTKAandashortpostoperativestayreceivedeitherPMMA+FNB(FNBgroup;n = 19)orPMMAonly(PMMAgroup;
n = 20). No preoperative group diﬀerences were noted. Evaluations occurred in hospital and at 2, 6, and 12 weeks postoperatively.
The primary outcome (knee ﬂexion) was measured on day two postoperatively. Rehabilitation indices, pain, analgesic use, and
length of stay (LOS) were also measured. Results. All subjects completed the study. The only signiﬁcant group diﬀerences were
quadriceps motor blocks in the FNB group (P<0.001). No signiﬁcant diﬀerences were noted in ROM, pain levels, analgesic use,
or hospital LOS. Conclusion. Other than the quadriceps motor block, no group diﬀerences were noted; both achieved satisfactory
analgesia. Best postoperative pain management strategies when following a short hospital stay program are still unclear.
1.Introduction
Total knee arthroplasty (TKA) is a common procedure for
treatment of end-stage arthritis and can signiﬁcantly im-
prove pain and function [1]. Despite long-term beneﬁts,
TKA is also associated with substantial early postoperative
pain; thus, pain management is critical [2].
During the past decade, perioperative care for patients
undergoing TKA has been changing rapidly including anal-
gesia. In the 1990s, patients frequently remained in hospital
for more than 1 week postoperatively [3, 4]. This is in direct
contrast to current reports of hospital length of stay (LOS)
of three days or less [5, 6]. To achieve early discharge, reha-
bilitation is often started the day of surgery. Thus, optimal
pain management is vital to allow patients to tolerate early
and frequent therapy during their short hospital stay.
Accompanying changes in postoperative care are multi-
ple pain management strategies including multimodal an-
algesia, nerve blockades, and preemptive analgesia [2, 7–
9]. Multimodal analgesia regimens often combine oral med-
ications (e.g., nonnarcotic analgesics, narcotic analgesics,
and anti-inﬂammatory medication) and nerve blockades to
decrease narcotic consumption.
Femoral nerve blockades (FNBs) signiﬁcantly improve
pain and knee range of motion (ROM) and reduce narcotic
consumption relative to patient-controlled analgesia (PCA)
or oral/intravenous narcotics [8, 10–13]. However, FNBs
are also frequently associated with quadriceps weakness and2 The Scientiﬁc World Journal
have been associated with falls postoperatively [14]. Thus,
their overall eﬀectiveness is uncertain when early discharge
programs are utilized [15, 16].
Preemptive multimodal analgesia (PMMA) is also being
used where patients take analgesics preoperatively (preemp-
tive) to prevent central sensitization and ampliﬁcation of
postoperative pain and combine multiple types/routes of
analgesics (multimodal) to maximize analgesia with the few-
est side eﬀects [2, 9, 17, 18]. PMMA often includes FNB;
there appear to be few reports of PMMA without FNB.
This pilot study examined the impact of the PMMA
regimen with the addition of an FNB compared with usual
care—an oral PMMA regimen without FNB. The overall
goal was to examine the eﬀect of PMMA including FNB
on discharge knee ﬂexion and in-hospital pain compared
to PMMA without FNB following primary TKA. Further,
we compared the impact of the pain management strategies
on (a) rehabilitation indices, (b) hospital LOS, (c) analgesic
use, and (d) pain and knee ROM at two, six, and 12 weeks
postoperatively.
The primary objective was to determine the impact of
PMMAwithFNBonkneeﬂexionmeasuredondaytwopost-
operatively compared to PMMA without FNB. Secondary
objectivesweretocomparepostoperative pain,rehabilitation
indices (quadriceps block and rehabilitation participation)
during the ﬁrst two postoperative days, and hospital LOS
in these same two patient groups. Finally, we compared
postoperative analgesic use and postdischarge pain and knee
ROM at weeks two, six, and 12 postoperatively.
2.MaterialsandMethods
This was a prospective pilot study undertaken at two tertiary
hospitals that perform high volumes of TKA annually. Both
hospitals followed the same regional clinical pathway for
preoperative, perioperative, and postoperative care, includ-
ing standardized medical and analgesic orders as well as a
standardized rehabilitation approach for postoperative care.
Care standardization is evaluated across sites to ensure that
sites are compliant with the regional clinical pathway.
All subjects (n = 39) were managed at the same central
intake and follow-up clinic that used standardized pre- and
posthospital care. This sample size allowed detection of 10-
degree diﬀerence in knee ﬂexion (α = 0.05; power = 0.80),
while accounting for 10% attrition, appropriate for our pilot
study.
In one hospital, anesthesiologists added FNB to the
PMMA regimen (FNB group (n = 19)), while the second
site used PMMA without FNB (PMMA group (n = 20)) as
perusualcare.Oralmedicationsdosageswereadjustedinthe
FNB group to ensure adequate pain control as needed. All
subjectsprovidedinformedconsent,andtheHealthResearch
Ethics Board approved the study.
To be eligible, subjects had preoperative knee ROM
≥90 degrees, body mass index (BMI) less than 40, and no
knownhepaticinsuﬃciencyorcontraindicationstoFNBand
did not regularly use narcotics preoperatively. Subjects were
English-speaking so that pain could be accurately assessed
using a visual analogue scale (VAS).
Subjects who met the selection criteria and were willing
to participate signed an informed consent preoperatively.
Subjects reported current pain levels using a VAS, preoper-
ative analgesic use (both narcotic and nonnarcotic), activity
levels, and general demographic/medical (e.g., age, sex, and
comorbidities) information to a research associate not in-
volved in their clinical care. Knee ROM was also assessed.
Allsurgeriesweredoneusingstandardsurgicaltechnique
(i.e., midline incision and medial parapatellar exposure). No
minimally invasive techniques were used. In the FNB group,
17 (89%) subjects received general anaesthesia with the oth-
ers (11%) receiving spinal anaesthesia. In the PMMA group,
16 (80%) received spinal anaesthesia with the remaining
subjects undergoing general anaesthesia.
2.1. Preemptive Analgesia. All subjects in both groups re-
ceivedOxycodonecontrolledrelease(10milligrams(mg)per
oral (PO)) and Celecoxib (100mg PO) within two hours
of surgery. Celecoxib (100–200mg PO) was administered
twice daily starting 12 hours after the preoperative dose and
continued throughout their hospital stay for all subjects.
2.2. PMMA. Postoperatively, the PMMA group received Ox-
ycodone controlled release (10–20mg PO) twice daily for
ﬁve doses starting 12 hours after the preoperative dose. For
breakthrough pain, subjects received up to two tablets of
acetaminophen (325mg with codeine 30mg) or acetam-
inophen (325mg with oxycodone 5mg) every four hours
as required. These were the primary analgesics used once
the Oxycodone controlled release doses were completed. If
oral analgesics were ineﬀective, subcutaneous morphine or
hydromorphone (if intolerant of morphine) was used with a
dose range of 0.5–3mg.
2.3. FNB. FNB subjects had femoral nerve catheters placed
preoperatively using ultrasound guidance via in-plane
approach. Choice of concentration, type, and volume of
local anesthetic was left to the attending anesthesiologist’s
discretion. A local anesthetic bolus of 0.1–0.5% ropivacaine
was administered via the femoral catheter with or without
0.125–0.25%bupivacaine(median20millilitres(mL),0.25%
ropivacaine,and0.125%bupivacaine).Inaddition,16(84%)
subjects also received a single-shot anterior sciatic nerve
block at the time of surgery at the discretion of the attending
anesthesiologist. Subjects were then anesthetized for the
TKA in the operating room. Subjects received narcotics
intraoperativelyattheattendinganesthesiologist’sdiscretion.
All morphine received was recorded.
Subjects were monitored regularly while the FNB was
in situ receiving 0.1-0.2% ropivacaine at a rate of 1–
6mL per hour as needed for pain control. Subjects with
continuous infusion received an additional 4–8mL per hour
while those receiving intermittent boluses (2% lidocaine,
0.5%bupivacaine,and/or0.1-0.2%ropivacaine)hadvarying
quantities (6–30mL). Anesthesiologists ordered additional
analgesia as required for adequate analgesia following the
recommendations of the oral PMMA regimen. The FNB
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which subjects followed the PMMA regimen until hospital
discharge. All narcotic use was recorded.
2.4. Postoperative Management. Mobilization started the day
of surgery at both sites as all subjects followed the same
regional pathway; subjects sat on the edge of the bed or in
a chair, or ambulated up to ﬁve feet, dependent upon their
tolerance. On each subsequent day, subjects attended reha-
bilitation twice a day to perform exercises and ambulate. The
goalwasdischargehomeonthethirdpostoperativemorning.
To be discharged, subjects had adequate pain control on oral
analgesics, performed self-care and transfers independently,
and ambulated weight-bearing as tolerated independently
with walking aids. Although not necessary for discharge, the
goal was at least 60 degrees of knee ﬂexion by the second
postoperative day.
Knee ﬂexion and pain were measured daily in hospital.
We expected to measure knee ﬂexion at hospital discharge,
but subjects were frequently discharged on day three prior to
measuring ROM. Thus, to fairly compare postoperative knee
ﬂexion between groups, the primary ﬂexion comparison
occurred on day two postoperatively.
Rehabilitationindices(quadricepsblock,participationin
rehabilitation), hospital narcotic analgesic use,and LOSwere
also recorded. After discharge, pain and knee ﬂexion were
e v a l u a t e da tt w o ,s i x ,a n d1 2w e e k sp o s t o p e r a t i v e l y .
3. Outcome Measures
3.1. Knee Flexion. Knee ﬂexion was measured in supine lying
usingagoniometer,whichhasbeenshowntobereliable[19].
3.2. Pain. Pain was measured at the start of rehabilitation
using an 11-point VAS (0–10), shown to be a reliable
and valid method of measuring patient-reported pain [20].
Subjects gave their verbal pain rating based on zero being
“no pain present” and 10 being “the worst pain imagina-
ble.”
3.3. Quadriceps Block. Subjects had a positive quadriceps
block if they were unable to actively contract or produce a
motor response of their quadriceps.
3.4. Participation in Rehabilitation. Participation in rehabil-
itation was measured as a count of rehabilitation sessions.
Subjects were expected to have one session on the day of
surgery and two sessions/day thereafter in hospital.
3.5. Analgesic Use. All narcotic medication was recorded and
standardized. For the ﬁrst three postoperative days (includ-
ing surgical day), the total amount of any narcotic used
was converted to the equivalent IM morphine dose using a
morphine equivalency scale [21]. The resulting equivalents
weretotaledtogiveasinglescorereﬂectingthetotalnarcotics
used.
Table 1: Baseline characteristics.
FNB
(n = 19)
PMMA
(n = 20) P-value
Demographics
Male (%) 12 (57) 9 (43) 0.34∗
Mean age (SD) 66.7 (7.9) 65.8 (8.4) 0.27†
Function
Mean knee ﬂexion (SD) 119.3 (11.5) 118.6 (10.9) 0.83†
Walks <6 blocks (%) 17 (91) 16 (80) 0.63∗
Uses no aide (%) 10 (53) 13 (65) 0.33∗
Pain
VAS score (SD) 6.5 (2.3) 5.2 (2.3) 0.09†
FNB: femoral nerve block, PMMA: preemptive multimodal analgesia, SD:
standard deviation, and VAS: visual analogue scale.
∗Analyzed using chi-square test.
†Analyzed using independent t-test.
4.Analysis
Knee ﬂexion at discharge was the primary outcome and was
analyzed using independent t-tests. Because there were no
baseline diﬀerencesnoted between groups, the meanpostop-
erative knee ﬂexion was chosen as the appropriate compari-
son. Pain levels were also assessed using independent t-tests.
Rehabilitation indices (quadriceps block and rehabilitation
participation) and analgesic use were analyzed using chi-
square tests. LOS was analyzed using the Mann-Whitney U
test for nonparametric data. Postdischarge pain and knee
ﬂexion were analyzed using independent t-tests.
Statistical analyses were performed with Predictive Ana-
lytics SoftWare (PASW) version 17.0 (SPSS: An IBM Com-
pany, Chicago, Ill, USA) utilizing 2-tailed tests. Although we
calculated the sample size based on a level of signiﬁcance
of P<0.05, we reset the level of signiﬁcance at P<0.01
prior to analysis because we evaluated multiple outcomes
over repeated time intervals.
5. Results
5.1. Baseline Characteristics. Subjects were similar in age,
gender distribution, and comorbidities and reported no dif-
ferences in preoperative function and knee ﬂexion (Table 1).
A l ls u b j e c t sc o m p l e t e dt h es t u d y .U s eo fp r e o p e r a t i v e l y
analgesic medication was also similar between groups (P>
0.80) although the FNB group reported nonsigniﬁcantly
higher pain levels preoperatively than the PMMA group
(Table 1).
5.2. Knee Flexion. Knee ﬂexion was similar between groups
on both the ﬁrst and second postoperative days (Table 2).
5.3. In Hospital Postoperative Pain and Analgesic Use. The
FNB group reported nonsigniﬁcantly higher mean pain
scores during the hospital stay (Table 2). In terms of medi-
cation use, the median morphine equivalency units for in-
hospitalanalgesicusewerenonsigniﬁcantlylowerintheFNB4 The Scientiﬁc World Journal
Table 2: In-hospital measures.
FNB
(n = 19)
PMMA
(n = 20) P value
Mean knee ﬂexion
Day 1 postoperatively (SD) 56.7 (16.8) 51.9 (11.3) 0.31†
Day 2 postoperatively (SD) 63.1 (16.2) 61.1 (12.1) 0.67†
Mean pain levels using VAS
Day 1 postoperatively (SD) 5.0 (1.9) 4.3 (1.7) 0.21†
Day 2 postoperatively (SD) 5.4 (2.4) 4.1 (1.7) 0.08†
Rehabilitation indices
Quadriceps block
Day 0 (%) 10 (53) 0 (0) <0.001∗
Day 1 (%) 13 (68) 0 (0) <0.001∗
Day 2 (%) 4 (22) 0 (0) 0.046∗
Missed rehabilitation
participation
Day 0 (%) 8 (42) 5 (25) 0.32∗
FNB: femoral nerve block, MMA: preemptive multimodal analgesia, SD:
standard deviation, and VAS: visual analogue scale.
†Analyzed using independent t-test.
∗Analyzed using Chi Square test.
group (59.6 (IQR 46.6, 130.4) versus 67.4 (IQR 46.4, 84.3))
than in the PMMA group (P = 0.19 by Mann Whitney U
test), but the mean analgesic use was nonsigniﬁcantly higher
in the FNB (84.17 (51.2)) than in the PMMA (67.33 (24.3))
group (P = 0.21 by independent t-test).
5.4. Rehabilitation Indices. FNB subjects were signiﬁcantly
more likely to have quadriceps blocks on the day of surgery
(day 0) and ﬁrst postoperative day than the PMMA subjects
(Table 2). Fewer FNB subjects were able to participate in
rehabilitation on the day of surgery, but this diﬀerence
was not signiﬁcant (P = 0.32). Despite more quadriceps
blocks in the FNB group, no subjects in either group missed
rehabilitation sessions after the day of surgery. Further, no
subjects experienced any falls postoperatively.
5.5. LOS. The median LOS was 4 (interquartile range 4,5)
daysintheFNBgroupand3.5(3,4)daysinthePMMAgroup
(P = 0.04), although this diﬀerence did not reach the ap ri o ri
level of signiﬁcance, which was set at α = 0.01.
5.6. Postdischarge Pain and Knee Flexion. There was no dif-
ference in pain or knee ROM at the postdischarge follow-
ups (Table 3). Few subjects in either group were using
narcotic analgesic beyond the two-week postoperative visit
with similar narcotic use between groups (P>0.42).
6. Discussion
Pain management following TKA is highly variable and
continues to evolve with changing postoperative care. FNB
appears more eﬀective than PCA in managing postoperative
pain,preventingnausea/vomiting,andincreasingkneeROM
Table 3: Postdischarge outcomes.
FNB PMMA P value
Postdischarge pain
2 weeks (SD) 4.0 (2.6) 4.4 (2.4) 0.72†
6 weeks (SD) 2.8 (2.2) 2.9 (2.4) 0.93†
12 weeks (SD) 1.1 (1.9) 2.0 (2.2) 0.31†
Postdischarge knee ﬂexion
2 weeks (SD) 84.7 (10.4) 83.1 (9.8) 0.69†
6 weeks (SD) 101.3 (13.4) 97.4 (13.2) 0.40†
12 weeks (SD) 110.9 (9.6) 105.0 (11.7) 0.14†
FNB: femoral nerve block, PMMA: preemptive multimodal analgesia, SD:
standard deviation, and VAS: visual analogue scale.
†Analyzed using independent t-test.
following primary TKA [2, 8]. However, FNB has been asso-
ciated with increased postoperative falls due to quadriceps
weakness; thus their utility may be more limited with aggres-
sive postoperative rehabilitation [14]. Our controlled pilot
study compared two pain management protocols, one in
w h i c hs u b j e c t sf o l l o w e da no r a lP M M Ao n l ya n do n ei n
whichsubjectsfollowedanadaptedPMMAaugmentedbyan
FNB. We found no signiﬁcant diﬀerences between groups in
terms of knee ﬂexion or reported postoperative pain up to 12
weeks postoperatively. Further, analgesic use did not appear
diﬀerent between groups. The FNB group reported more
quadriceps motor blocks, a common side eﬀect attributed
to FNB [15, 16, 22, 23]. However, no patient experienced
falls, and the two groups reported similar rehabilitation
attendance in hospital. The FNB group stayed a half day
longer in hospital than the PMMA group, but this diﬀerence
was not signiﬁcant.
Past studies compared FNB to PCA regimens or to dif-
ferent nerve block techniques and demonstrated that FNB is
an eﬀective pain management strategy following TKA [10–
13, 22, 24]. Recent guidelines suggest that FNB should be
used as routine care following TKA [2]. However, based on
the reported association of increased fall risk with FNB [14],
further evaluation of FNB is necessary, particularly in the
context of short stay postoperative protocols. Despite more
quadriceps block in the FNB group, we found no diﬀerence
in rehabilitation attendance or knee ﬂexion between PMMA
with FNB and PMMA alone; both groups reported similar
postoperativeanalgesia.AspreviousreportsonPMMAeﬀec-
tiveness have typically included FNB as part of the regimen
[9, 24, 25], our study adds to current evidence by comparing
the impact of PMMA with and without an FNB when a short
stay postoperative protocol is utilized.
Our study has several strengths; this was a prospective
controlled pilot study where all participants were screened
and followed postoperatively at a single centre and received
standardized pre-, peri-, and postoperative care except for
pain management. We also assessed several important out-
comes, rather than just the most commonly reported pain
or analgesia [10–12]. We examined the impact of the
analgesic regimes on rehabilitation including knee ﬂexion
and quadriceps weakness. With evolving postoperative careThe Scientiﬁc World Journal 5
moving to early rehabilitation and short LOS, patients’
pain must be adequately controlled without impeding time
to discharge or aﬀecting patient safety. Therefore, these
additional outcomes are important to measure to determine
optimal pain management after TKA.
However, there are also limitations to our study. We did
not randomize subjects but instead evaluated the impact
of adding an FNB to an established oral PMMA regimen
at one hospital. Thus, it is possible that the measured
outcomes were aﬀected by hospital diﬀerences despite using
a regional care pathway. Further, FNB technique was not
standardized and was left to the discretion of the attending
anaesthesiologist. These variations could aﬀect the FNB
eﬃcacy; however, our study reﬂects the eﬀectiveness of an
FNB applied under usual clinical standards as determined by
the attending anaesthesiologist.
Finally, our pilot study is small; the study was under-
powered for the primary outcome at the level of signiﬁcance
analyzed (P< 0.01). However, at no time was more than
a six-degree diﬀerence in knee ROM reported between
groups, so no clinically important diﬀerences were deemed
nonsigniﬁcant by our revised level of signiﬁcance. Further
study is needed to determine if similar results occur using
a randomized study design, standardized regimens, and a
larger sample.
There is much heterogeneity in regard to optimum post-
TKA analgesia due to multiple changes in surgical practice
andpostoperativecare,reducingtheapplicabilityofprevious
studies to current care. To date, there is no answer as to best
practices for pain management following TKA. An oral
PMMA regimen with or without augmentation of an FNB
appears to provide adequate analgesia. Further research
should also consider outcomes beyond analgesia and mea-
sure the impact of the analgesic regimen on patients overall
postsurgical recovery.
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